(6)	GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company has recorded goodwill of $413.3 from the acquisitions of Counsyl that was completed on July 31, 2018, Assurex that was completed on August 31, 2016, Sividon Diagnostics GmbH (“Sividon”) that was completed on May 31, 2016, Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG (the “Clinic”) that was completed on February 27, 2015, Crescendo Bioscience, Inc. that was completed on February 28, 2014 and Rules-Based Medicine, Inc. that was completed on May 31, 2011. Of this goodwill, $347.5 relates to the Company’s diagnostic segment and $65.8 relates to the other segment. The following summarizes changes to the goodwill balance for the three months ended September 30, 2018:

	Carrying amount
Beginning balance July 1, 2018	$	318.6
Acquisitions		94.9
Translation adjustments		(0.2	)
Ending balance September 30, 2018	$	413.3

Intangible Assets

Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development. The following summarizes the amounts reported as intangible assets:

	Gross
	Carrying		Accumulated
	Amount		Amortization			Net
At September 30, 2018:
Purchased licenses and technologies	$	819.1	$	(111.4	)	$	707.7
Customer relationships		4.6		(3.4	)		1.2
Trademarks		3.0		(1.0	)		2.0
Total amortized intangible assets		826.7		(115.8	)		710.9
In-process research and development		23.3		—			23.3
Total unamortized intangible assets		23.3		—			23.3
Total intangible assets	$	850.0	$	(115.8	)	$	734.2

	Gross
	Carrying		Accumulated
	Amount		Amortization			Net
At June 30, 2018:
Purchased licenses and technologies	$	526.4	$	(98.0	)	$	428.4
Customer relationships		4.6		(3.3	)		1.3
Trademarks		3.0		(1.0	)		2.0
Total amortized intangible assets		534.0		(102.3	)		431.7
In-process research and development		23.5		—			23.5
Total unamortized intangible assets		23.5		—			23.5
Total intangible assets	$	557.5	$	(102.3	)	$	455.2

The Company recorded amortization expense during the respective periods for these intangible assets as follows:

	Three months ended
	September 30,
	2018		2017
Amortization of intangible assets	$	13.4	$	9.3